These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21852760)

  • 21. Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.
    Court F; Le Boiteux E; Fogli A; Müller-Barthélémy M; Vaurs-Barrière C; Chautard E; Pereira B; Biau J; Kemeny JL; Khalil T; Karayan-Tapon L; Verrelle P; Arnaud P
    Genome Res; 2019 Oct; 29(10):1605-1621. PubMed ID: 31533980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation.
    Si J; Boumber YA; Shu J; Qin T; Ahmed S; He R; Jelinek J; Issa JP
    Cancer Res; 2010 Sep; 70(17):6968-77. PubMed ID: 20713525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.
    Nguyen CT; Weisenberger DJ; Velicescu M; Gonzales FA; Lin JC; Liang G; Jones PA
    Cancer Res; 2002 Nov; 62(22):6456-61. PubMed ID: 12438235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.
    Claus R; Fliegauf M; Stock M; Duque JA; Kolanczyk M; Lübbert M
    J Leukoc Biol; 2006 Dec; 80(6):1462-72. PubMed ID: 17000900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116.
    Fang JY; Chen YX; Lu J; Lu R; Yang L; Zhu HY; Gu WQ; Lu LG
    Cell Res; 2004 Jun; 14(3):217-26. PubMed ID: 15225415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma.
    Ribarska T; Ingenwerth M; Goering W; Engers R; Schulz WA
    Cancer Genomics Proteomics; 2010; 7(2):51-60. PubMed ID: 20335518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines.
    Lambrot R; Kimmins S
    Int J Androl; 2011 Apr; 34(2):110-23. PubMed ID: 20497257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis.
    Curry E; Zeller C; Masrour N; Patten DK; Gallon J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Bowtell DD; Brown R
    Cancer Res; 2018 Mar; 78(6):1383-1391. PubMed ID: 29339543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.
    Obata T; Toyota M; Satoh A; Sasaki Y; Ogi K; Akino K; Suzuki H; Murai M; Kikuchi T; Mita H; Itoh F; Issa JP; Tokino T; Imai K
    Clin Cancer Res; 2003 Dec; 9(17):6410-8. PubMed ID: 14695142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells.
    Zhu X; Mao X; Hurren R; Schimmer AD; Ezzat S; Asa SL
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3610-7. PubMed ID: 18544619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory.
    Raynal NJ; Si J; Taby RF; Gharibyan V; Ahmed S; Jelinek J; Estécio MR; Issa JP
    Cancer Res; 2012 Mar; 72(5):1170-81. PubMed ID: 22219169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
    J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.
    Suzuki H; Igarashi S; Nojima M; Maruyama R; Yamamoto E; Kai M; Akashi H; Watanabe Y; Yamamoto H; Sasaki Y; Itoh F; Imai K; Sugai T; Shen L; Issa JP; Shinomura Y; Tokino T; Toyota M
    Carcinogenesis; 2010 Mar; 31(3):342-9. PubMed ID: 19638426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactivating the expression of methylation silenced genes in human cancer.
    Karpf AR; Jones DA
    Oncogene; 2002 Aug; 21(35):5496-503. PubMed ID: 12154410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation and gene silencing in cancer.
    Baylin SB
    Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S4-11. PubMed ID: 16341240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.
    Raynal NJ; Lee JT; Wang Y; Beaudry A; Madireddi P; Garriga J; Malouf GG; Dumont S; Dettman EJ; Gharibyan V; Ahmed S; Chung W; Childers WE; Abou-Gharbia M; Henry RA; Andrews AJ; Jelinek J; Cui Y; Baylin SB; Gill DL; Issa JP
    Cancer Res; 2016 Mar; 76(6):1494-505. PubMed ID: 26719529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
    Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
    Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation and cancer.
    Kulis M; Esteller M
    Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.